BSE · BERLDRG
Beryl Drugs Ltd. (BERLDRG) Share Price
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#4,445
of 5,047 stocks
▼ 521W→ 01M
Peak #4,344 · 02 Oct 2026
Beryl Drugs Ltd., a microcap Healthcare business, carries a steep earnings multiple that prices in strong future growth, has a subdued return on equity, and has a widely-held ownership base, with promoters at just 28%.
Market Cap
12.47 Cr
P/E Ratio
81.97
P/B Ratio
1.26
ROE
4.30%
ROCE
8.94%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 7.30 Cr | 5.13 Cr | 3.78 Cr | 5.12 Cr |
| Net Profit | 22.08 L | 56.25 L | -16.77 L | Rs 89,000 |
| EPS | 0.44 | 1.11 | -0.33 | 0.02 |
| Operating Profit | 33.18 L | 93.73 L | -51.61 L | 34.05 L |
Shareholding pattern
Promoter
27.82%
Public
72.18%
PUBLIC BREAKDOWN
Individuals
67.62%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 23 Aug 2002 | Dividend | NIL Dividend - Rs. - 0.0000 |
Other Healthcare stocks
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.